logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Kyung-Hun Lee

Konyang University Hospital
H指数:45
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Heterogeneity of breast and nodal response to neoadjuvant pembrolizumab-based chemoimmunotherapy in early triple-negative breast cancer and its clinical significance

早期三阴性乳腺癌对基于帕博利珠单抗的新辅助化免疫治疗的乳腺和淋巴结反应异质性及其临床意义

Histopathology
IF4.1
2026-09-250
PRE
Jiwon Koh; Koung Jin Suh; Hye Yeon Park; Hyun Jung Kwon; Hyun-Jung Sung; Han Suk Ryu; Jung Ho Kim; Jaemoon Koh; Kyung-Hun Lee; Dae-Won Lee; Changhee Park; Jeongmin Seo; Heejung Chae; Woochan Hwang; Ye Yoon Suh; Chang Ho Ahn; Seock-Ah Im; Jee Hyun Kim; So Yeon Park
Phase II study of trastuzumab-pkrb plus gedatolisib in patients with HER2-positive metastatic breast cancer who progressed after two or more HER2-directed therapies

曲妥珠单抗-pkrb联合吉地洛昔布在HER2阳性转移性乳腺癌患者中的II期研究，该患者在接受两种或更多HER2靶向治疗后进展

ESMO Open
IF8.3
2026-07-011
OAAI
Kim, J. W.; Park, V. H.; Lee, S.; Ahn, H. K.; Bae, J.; Park, S.; Chae, H.; Kim, J. H.; Lee, K. -h.; Kim, M. H.; Lee, K. E.; Kang, M. J.; Park, I. H.; Chae, V. s.; Lee, G. W.; Park, K. U.; Lee, E. M.; Park, J. H.; Kim, J. E.; Kim, H. K.; Kim, T. H.; Oh, S. V.; Ko, S.; Byun, J. H.; Ha, J. V.; Kwon, J. H.; Choi, J. V.; Jung, J. V.; Park, K. H.
A Randomized Phase III Trial of Anthracyclines Followed by Taxane versus Taxane Plus Carboplatin as (Neo)Adjuvant Therapy in Patients with Triple-Negative Breast Cancer: KCSG BR 15-1 PEARLY Trial

在三阴性乳腺癌患者中，蒽环类药物联合紫杉烷与紫杉烷加卡铂作为 (新) 辅助治疗的随机III期试验: KCSG BR 15-1 PEARLY试验

Annals of Oncology
IF65.4
2026-05-300
OAAI
G.M. Kim; K.H. Jung; H.C. Jeung; J. Lee; K.S. Lee; S.A. Im; S.Y. Kang; S.H. Kim; H.J. Kim; K.H. Park; Y.S. Chae; S.J. Koh; E.K. Cho; K.U. Park; S.S. Lee; J.Y. Kim; I.S. Choi; S.K. Baek; Y.W. Moon; S.G. Kim
Impact of trastuzumab deruxtecan (T-DXd) and brain stereotactic radiosurgery on intracranial control and radionecrosis risk in HER2-positive or -low breast cancer brain metastases

曲妥珠单抗德鲁替康（T-DXd）与脑立体定向放射外科对HER2阳性或低表达乳腺癌脑转移颅内控制及放射性坏死风险的影响

Breast
IF7.9
2026-03-010
OAAI
Chun, Seok-Joo; Kim, Kyubo; Chang, Won Ick; Kim, Yong Bae; Paek, Sun Ha; Lee, Kyung-Hun; Song, Jin-Ho; Hong, Ji Hyun; Lee, Jieun; Jang, Won Il; Kim, Tae Hyun; Shin, Kyung Hwan
Elimusertib, a Novel ATR Inhibitor, Induces Anti-tumor Effects through Replication Catastrophe in Breast Cancers

Kim, M.; Min, A.; Kim, S.; Kim, S.; Kim, Y.J.; Ham, S.; Lee, M.; Lee, E.Y.; Kim, J.; Lee, D.W.; et al. Elimusertib，一种新型ATR抑制剂，通过复制灾难在乳腺癌中诱导抗肿瘤效应。Cancer Res. Treat. 2025; Online ahead of print. [Google Scholar] [CrossRef]

Cancer Research and Treatment
IF3.8
2026-01-011
OA
Kim, Mudong; Min, Ahrum; Kim, Sohyeon; Kim, Seongyeong; Kim, Yu-jin; Ham, Sujin; Lee, Miso; Lee, Eunice Yoojin; Kim, Jinyong; Lee, Dae-Won; Lee, Kyung-Hun; Im, Seock-Ah
Genomic and transcriptomic analyses of residual invasive triple-negative breast cancer after neoadjuvant chemotherapy in the prospective MIRINAE trial (a randomized phase II trial of adjuvant atezolizumab plus capecitabine compared to capecitabine; KCSG-BR18-21)

MIRINAE试验（一项比较辅助阿替利珠单抗联合卡培他滨与单用卡培他滨的随机II期试验；KCSG-BR18-21）中，新辅助化疗后残留浸润性三阴性乳腺癌的基因组学和转录组学分析

ESMO Open
IF8.3
2025-09-240
PREAI
S.-A. Im; K. Park; J. Koh; C. Park; K.H. Jung; J. Lee; H.K. Ahn; A. Lee; S.H. Sim; M.H. Kim; J.H. Kim; J.H. Kim; K.E. Lee; K.H. Park; J. Bae; M.H. Lee; S. Lim; H.J. Kim; D.-W. Lee; J.H. Jeong; K.S. Lee; J. Sohn; K.J. Suh; J.-Y. Kim; Y.J. Cha; J. Moon; C.-Y. Ock; S.-B. Kim; K. Shin; H. Chae; G.M. Kim; K.-H. Lee; W.-Y. Park; Y.H. Park; I.H. Park
Establishment and characterization of 24 breast cancer cell lines and 3 breast cancer organoids reveals molecular heterogeneity and drug response variability in malignant pleural effusion-derived models

建立和表征24种乳腺癌细胞系和3种乳腺癌类器官，揭示恶性胸腔积液衍生的模型中的分子异质性和药物反应可变性

BREAST CANCER RESEARCH
IF5.6
2025-05-010
OA
Kim, Soon-Chan; Kim, Ga-Hye; Park, Jae-Hyeon; Lee, Kyung-Hun; Koh, Jiwon; Kim, Tae-Yong; Lee, Dae-Won; Kim, Yu-Jin; Kim, Seongyeong; Park, Song-Yi; Min, Ahrum; Shin, Young-Kyoung; Im, Seock-Ah; Ku, Ja-Lok
[1] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209-249.

[1] Sung H, Ferlay J, Siegel RL, 等. 全球癌症统计数据2020：185个国家36种癌症的全球发病率与死亡率GLOBOCAN估算. CA Cancer J Clin 2021;71:209-249.

JHEP REPORTS
IF7.5
2025-02-010
PRE
Finn, Richard S.; Gu, Kangsheng; Chen, Xi; Merle, Philippe; Lee, Kyung-Hun; Bouattour, Mohamed; Cao, Peiguo; Wang, Wei; Cheng, Ann-Lii; Zhu, Liangjun; Lim, Ho Yeong; Kudo, Masatoshi; Pan, Yueyin; Chang, Ting-Tsung; Edeline, Julien; Li, Wei; Yang, Ping; Li, Chen; Li, Jianfeng; Siegel, Abby B.; Qin, Shukui
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients with HR-positive/HER2-negative advanced breast cancer
NPJ BREAST CANCER
IF7.6
2024-08-220
OA
Noguchi, Emi; Yamanaka, Takashi; Mukai, Hirofumi; Yamamoto, Naohito; Chung, Chi-Feng; Lu, Yen-Shen; Chang, Dwan-Ying; Sohn, Joohyuk; Kim, Gun Min; Lee, Kyung-Hun; Lee, Soo-Chin; Iwasa, Tsutomu; Iwata, Hiroji; Watanabe, Kenichi; Jung, Kyung Hae; Tanabe, Yuko; Kang, Seok Yun; Yasojima, Hiroyuki; Aogi, Kenjiro; Tokunaga, Eriko; Sim, Sung Hoon; Yap, Yoon Sim; Matsumoto, Koji; Tseng, Ling-Ming; Umeyama, Yoshiko; Sudo, Kazuki; Kojima, Yuki; Hata, Tomomi; Kuchiba, Aya; Shibata, Taro; Nakamura, Kenichi; Fujiwara, Yasuhiro; Tamura, Kenji; Yonemori, Kan
Differential effects of desvenlafaxine on hot flashes in women with breast cancer taking tamoxifen: a randomized controlled trial

去甲文拉法辛对服用他莫昔芬的乳腺癌妇女潮热的差异作用: 一项随机对照试验

NPJ BREAST CANCER
IF7.6
2024-07-170
OAAI
Kim, Yongjoo; Yeom, Chan-Woo; Lee, Hyun Jeong; Kim, Jeong-Hyun; Lee, Kwang-Min; Kim, Tae-Yong; Lee, Han-Byoel; Kim, Hoon; Im, Seock-Ah; Lee, Kyung-Hun; Kim, Miso; Han, Wonsik; Moon, Hyeong-Gon; Spiegel, David; Hahm, Bong-Jin; Son, Kyung-Lak
Outcomes in Nonmetastatic Hormone Receptor-Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort Study
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
IF16.4
2024-06-010
OA
Tan, Ryan Ying Cong; Ong, Whee Sze; Lee, Kyung-Hun; Park, Seri; Iqbal, Jabed; Park, Yeon Hee; Lee, Jeong Eon; Yu, Jong Han; Lin, Ching-Hung; Lu, Yen-Shen; Ono, Makiko; Ueno, Takayuki; Naito, Yoichi; Onishi, Tatsuya; Lim, Geok-Hoon; Tan, Su-Ming; Lee, Han-Byoel; Koh, Jiwon; Han, Wonshik; Im, Seock-Ah; Tan, Veronique Kiak Mien; Phyu, Nitar; Wong, Fuh-Yong; Tan, Puay Hoon; Yap, Yoon-Sim
Comparison of clinical efficacy between letrozole plus ribociclib vs. Fulvestrant plus letrozole plus ribociclib in Hormone receptor positive, HER2 negative metastatic breast cancer - a randomized, phase 2 study (KCSG BR22-20)
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Lee, Jieun; Koh, Su-Jin; Kwon, Jung Hye; Kim, Gun Min; Kim, Jee Hung; Kim, Ho Young; Kim, Hee-Jun; Park, Keon-Uk; Park, Kyong Hwa; Park, Yeon Hee; Ahn, Mi Sun; Ahn, Hee Kyung; Lee, Gyeong-Won; Lee, Kyoung Eun; Lee, Kyung-Hun; Lee, Moon Hee; Lee, Sung Sook; Lee, Jung Lim; Jung, Kyung Hae; Jung, Joo Young; Park, In Hae

研究方向

暂未获取到该数据
S
Seock‐Ah Im
H 指数:98论文数:1,144被引数:6.8万
T
Tae‐Yong Kim
H 指数:34论文数:204被引数:3,633
D
Do‐Youn Oh
H 指数:81论文数:950被引数:4.3万
S
Sae‐Won Han
H 指数:57论文数:451被引数:1.1万
A
Ahrum Min
H 指数:18论文数:128被引数:1,367
Y
Yung‐Jue Bang
H 指数:106论文数:1,069被引数:6.7万
W
Wonshik Han
H 指数:66论文数:767被引数:1.6万
D
Dae‐Won Lee
H 指数:20论文数:91被引数:1,470
H
Han Suk Ryu
H 指数:33论文数:221被引数:4,648
Y
Yeon Hee Park
H 指数:48论文数:400被引数:1.6万